GISELA MD SCHWAB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GISELA MD SCHWAB.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GISELA MD SCHWAB. GISELA MD SCHWAB is a Chief Medical Officer in ABGENIX INC ($ABGX) and a EVP and Chief Medical Officer in EXELIXIS, INC. ($EXEL) and a Pres Prod Dev & Med Aff & CMO in EXELIXIS, INC. ($EXEL) and a Pres, Prod Dev & Med Aff & CMO in EXELIXIS, INC. ($EXEL) and a Director in GENOCEA BIOSCIENCES, INC. ($GNCA).
Address: 6701 KAISER DRIVE FREMONT 94555 CA
Companies in which GISELA MD SCHWAB is an Insider
ABGENIX INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of GISELA MD SCHWAB: Chief Medical Officer
Holdings: 0 shares
Latest Transaction: Apr 04 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
EXELIXIS, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of GISELA MD SCHWAB: Pres, Prod Dev & Med Aff & CMO, Pres Prod Dev & Med Aff & CMO, EVP and Chief Medical Officer
Holdings: 714,078 shares
Current Value: $14,688,584
Latest Transaction: May 14 2021
$EXEL Market Capitalization: $6.19B
$EXEL Previous Close: $20.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GENOCEA BIOSCIENCES, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of GISELA MD SCHWAB: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 18 2020
$GNCA Market Capitalization: $129.13M
$GNCA Previous Close: $4.51
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of GISELA MD SCHWAB
Sentiment: All, ABGX, EXEL, GNCA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Option Exercise | M | 1.90 | 100,000 | 190,000 | 150,000 | |
| May 14 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Sell | S | 25.38 | 100,000 | 2,538,000 | 614,078 | 714.1 K to 614.1 K (-14.00 %) |
| May 14 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Buy | M | 1.90 | 100,000 | 190,000 | 714,078 | 614.1 K to 714.1 K (+16.28 %) |
| Apr 28 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Option Exercise | M | 1.70 | 50,000 | 85,000 | 0 | |
| Apr 28 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Sell | S | 25.00 | 50,000 | 1,250,000 | 613,482 | 663.5 K to 613.5 K (-7.54 %) |
| Apr 28 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Buy | M | 1.70 | 50,000 | 85,000 | 663,482 | 613.5 K to 663.5 K (+8.15 %) |
| Apr 02 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Option Exercise | M | 1.70 | 50,000 | 85,000 | 50,000 |